| Introduction | Qomel Company is pleased to announce the signing of a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares in Kan Medical Company, a limited liability company (single-member company) specialized in the manufacturing of medical devices. This step aligns with the Company’s strategy to strengthen its presence in the medical devices sector, expand its business base, and capitalize on the growing opportunities in this market. The final acquisition percentage will be determined upon completion of the financial valuation and the due diligence process (financial, legal, and technical), and obtaining the required approvals. |
| Memorandum Signing Date | 2026-01-08 Corresponding to 1447-07-19 |
| Counterparty | Kan Medical Company |
| Memorandum Subject | Signing a non-binding Memorandum of Understanding with Kan Medical Company to acquire a stake ranging from 60% to 90% of the shares in Kan Medical Company, a limited liability company (single-member company), provided that the final acquisition percentage will be determined after completing the financial valuation, concluding the due diligence process, and obtaining the required approvals. |
| Memorandum Duration | 180 days from the MoU signing date (renewable upon mutual agreement of both parties). |
| Related Parties | None. |
| Financial Impact | There is currently no financial impact. Any material developments will be announced in due course. |
| Additional Information | - The MoU is non-binding and does not create any obligation on Qomel Company should the transaction not be completed or should the Company decide not to proceed for any reason.- The proposed acquisition remains subject to completion of the financial, legal, and technical due diligence process, the financial valuation, and obtaining the necessary approvals from the relevant authorities. |
